Trial intelligence / Profile preview

Bioavailability of Sildenafil Chewable Tablet vs Viagra in Healthy Volunteers

NCT00902512Phase 4Completed

Sponsor
Viatris
Start
Apr 2009
Primary completion
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ASP-001 in erectile dysfunction (ED) (3 arms), sponsored by Viatris. Primary endpoints: Area Under the Curve from Time 0 to Last Quantifiable Concentration at 28 days and Maximum Plasma Concentration at 28 days. Started Apr 2009; status: completed.

02

Drugs

ASP-001
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00902512.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00902512.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call